UK And EU May Sign A Vaccine Agreement

UK and the EU may sign a vaccine agreement. Britain wants to avoid threats of a supply shortage on vaccines.

According to the New York Times, Britain may sign a vaccine deal with the European Union (EU) this weekend to eliminate threats to halt the supply. With this agreement, it is predicted that the threats of the EU regarding the export of Pfizer-BioNTech vaccines to the UK will come to an end. In return, Britain will sacrifice part of the long-term supply of the Oxford-AstraZeneca vaccine which is produced in the Netherlands. According to the information obtained, on Friday, the European Medicines Agency approved the Halix production facility that produces the AstraZeneca vaccine in the Netherlands and the BioNTech/Pfizer vaccine production facility in Marburg, Germany. European Union Stiffens Export Rules On The Vaccine According to reports, the EU will be able to demand countries that import vaccines from the EU to return the vaccine when necessary, by tightening the existing export rules. At the same time, these rules will be factors that will determine whether exports will be allowed according to the country's vaccination rate and the state of the epidemic. European Commission President Ursula von der Leyen said, "We must ensure the timely and adequate supply of the vaccine for EU citizens. The EU is the only and largest OECD member exporting vaccines to other countries, but this path should be bilateral."